glp 1 agonists moa GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes Mechanism of action of GLP-1
Description
Early-phase results have been encouraging, with participants reporting fewer heavy drinking days and reduced cravings
A bottom-up approach was used to estimate and validate the total size of the GLP-1 Agonists market
doi: 10.1517/14656566.2014.965678
Conclusion GLP-1RAs are gaining attention as a new option for treating the obesity-related phenotype of HFpEF
